Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice
- 17 January 2018
- journal article
- research article
- Published by Wiley in Experimental Dermatology
- Vol. 27 (8) , 827-832
Abstract
Sphingomyelin synthase (SMS) is an enzyme that generates sphingomyelin (SM) from ceramide (CER) and phosphatidylcholine. SM in the epidermis is a precursor of CER, an important lipid for epidermal permeability barrier function. However, the physiological role of SMS in skin is unclear. To uncover the function of SMS in skin, we investigated sphingolipid metabolism enzyme activity in skin, SM content in the epidermis, CER content in the stratum corneum (SC) and transepidermal water loss (TEWL) as an indicator of barrier function in SMS2‐knockout (KO) mice. The activities of sphingolipid metabolism enzymes in skin homogenates were measured using a fluorescently labelled substrate. Enzymatic reaction products were detected by high‐performance liquid chromatography (HPLC). Lipids in the epidermis or SC were extracted and quantified by high‐performance thin layer chromatography (HPTLC). TEWL was measured using a Tewameter TM300. In SMS2‐KO mice, SMS activity in skin homogenates, epidermal SM content and SC CER content were significantly decreased relative to wild‐type (WT) mice. The TEWL of SMS2‐KO mice was significantly increased compared to WT mice. Our data indicate that SMS2 generates SM in the epidermis and contributes to epidermal permeability barrier function and will support understanding of SM‐related metabolic disorders.Keywords
This publication has 31 references indexed in Scilit:
- Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Subcellular Targeting Domains of Sphingomyelin Synthase 1 and 2Nutrition & Metabolism, 2011
- Reducing Plasma Membrane Sphingomyelin Increases Insulin SensitivityMolecular and Cellular Biology, 2011
- Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 DiabetesJournal of Biological Chemistry, 2011
- Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cellsLipids in Health and Disease, 2011
- Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Mitochondrial Dysfunction and Increased Reactive Oxygen Species Impair Insulin Secretion in Sphingomyelin Synthase 1-null MiceJournal of Biological Chemistry, 2011
- Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in MiceCirculation Research, 2009
- Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ERJournal of Cell Biology, 2009
- Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal deathHuman Molecular Genetics, 2007